A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
Robinson S, Delongeas JL, Donald E, Dreher D, Festag M, Kervyn S, Lampo A, Nahas K, Nogues V, Ockert D, Quinn K, Old S, Pickersgill N, Somers K, Stark C, Stei P, Waterson L, Chapman K.
Robinson S, et al. Among authors: stei p.
Regul Toxicol Pharmacol. 2008 Apr;50(3):345-52. doi: 10.1016/j.yrtph.2007.11.009. Epub 2007 Dec 5.
Regul Toxicol Pharmacol. 2008.
PMID: 18295384